In China, the registration and filing of medical devices are necessary steps to ensure that products are legally marketed. In particular, the registration and approval of drugs and medical devices requires companies to strictly comply with the regulations of the China National Medical Products Administration (NMPA, formerly CFDA). As a professional registration consulting service company, Beijing Hongmaokang Medical Technology Co., Ltd. (hereinafter referred to as “Hongmaokang”) is committed to providing full life cycle registration consulting services for medical device companies, including product development, system construction, registration/filing applications, pre-market product strategic planning, registration solutions and post-market supervision services.
Overview of NMPA Drug Registration Process
The main purpose of NMPA drug registration is to ensure that drugs and medical device products meet the safety, effectiveness and quality requirements of the Chinese market. The entire registration process can be divided into the following steps:
Product Development and Testing
Before registering drugs, sufficient product development and clinical trials are required first. Drugs and medical devices must undergo rigorous scientific verification to ensure their safety and effectiveness in the human body or the environment. Through cooperation with experts and scientific research institutions, companies can complete the necessary technical verification.
Registration Information Preparation
Companies need to prepare complete registration information, including product instructions, clinical trial reports, risk assessment reports, etc. All materials must comply with NMPA requirements to ensure that no important information is omitted. Hongmaokang’s professional consulting team can help companies organize and review materials efficiently.
Submit registration application
The registration application needs to be submitted to NMPA, and after passing the review of the review agency, the registration certificate for drugs or medical devices is obtained. This process may take 6 to 12 months, depending on the product category and complexity.
Post-market supervision and update
After obtaining the registration certificate, the product enters the market, but post-market supervision is still very important. NMPA requires regular testing and reporting of products that have been marketed to ensure that the products continue to meet safety standards. In addition, if there are any changes to the product (such as output current, label changes, etc.), it must be reported to NMPA in a timely manner to avoid affecting the legality of the product.
Frequently Asked Questions and Answers
1. What should be done if the instructions for use of the medical device change?
When the instructions for use of the medical device change, the company should update the registration information in a timely manner and submit a change application to NMPA. According to the relevant regulations of NMPA, if there are major changes in the basic performance, indications or methods of use of the product, the company needs to resubmit the registration application and undergo review.
2. When conducting a performance study of medical device products, do you need to consider the impact of product batches on product performance?
Yes, when conducting a product performance study, differences between batches may affect the quality and performance of the product. In order to ensure product consistency and stability, companies should pay attention to product batch management and conduct corresponding performance tests based on different batches.
3. If the output current of the charger of a registered medical device product changes and the corresponding label also changes, is it necessary to re-register?
If the output current of the charger changes and the change may affect the safety or use of the product, the company needs to report to NMPA and resubmit the registration application. Any changes that may affect product performance or use require re-evaluation and registration updates.
4. How to determine the timing of applying for registration renewal? Must an application be submitted six months before the expiration of the medical device registration certificate?
According to NMPA regulations, companies should submit a renewal application within 6 months before the expiration of the registration certificate. If the renewal application fails to be submitted within the prescribed time, the company must re-apply for registration in accordance with regulatory requirements, and the validity of the original registered product may be affected.
5. If the renewal application is not submitted within the prescribed time, can the original registered product continue to be used?
If the renewal application is not submitted within the specified time, the company cannot continue to sell or use the original registered product. At this time, the company needs to resubmit the registration application and ensure that the product meets all the latest regulatory requirements.
Advantages and services of Beijing Hongmaokang
As a professional medical device registration consulting company, Beijing Hongmaokang has an experienced team of experts who can provide customers with efficient registration services. Hongmaokang’s services are not limited to registration applications, but also include full technical support and regulatory consulting to help companies improve R&D, clinical trials, production and registration efficiency.
Professional team service:
Hongmaokang’s consulting team has multilingual communication capabilities and can provide personalized services for companies in different countries and regions. Whether it is a domestic company or a multinational company, Hongmaokang can tailor the best registration solution for it.
Market strategy and product planning:
Hongmaokang not only helps companies complete registration, but also provides product strategy planning and market prospect analysis to help companies occupy a favorable position in the highly competitive market.
Full life cycle service:
From product development, registration to market monitoring, Hongmaokang provides one-stop full life cycle services to help companies advance smoothly at each stage and reduce the time for market access.
NMPA drug registration is a complex and rigorous process. Companies need to carefully consider every detail when registering to ensure that their products meet all regulatory requirements for the Chinese market. Beijing Hongmaokang Medical Technology Co., Ltd., with its professional team and rich experience, can provide medical device companies with a full range of registration consulting services to help companies improve efficiency and accelerate market launch. Through cooperation with Hongmaokang, companies can focus on product innovation and development, easily cope with registration and compliance challenges, and lay a solid foundation for the successful launch of products.
